Jean Garrec, Pharm.D., M.B.A., and Jean Cuine, Pharm.D., Ph.D., M.B.A. | Bioadhesive Ophthalmics, France
Competition Sponsor: EIT Health
Awardee Year: 2020
The lack of adherence to Rx eye drops is the #1 Unmet Medical need in Ophthalmology, especially for the elderly population. Poor treatment Compliance and Adhesion leads to a worse progression of Eye Diseases. We will change lives of patients suffering from chronic eye diseases by creating a best-in-class solution to reduce the burden of treatments.
Our technology will disrupt the entire ophthalmic market by:
- Solving compliance with a once a week only application
- Topical & easy to apply solution
- Continuous accurate dosing with efficacy in multiple indications
Our new non-invasive topical ocular insert is aimed at several ophthalmic indications by allowing more effective treatments and better control of diseases. Two formulations using generic molecules will be initially evaluated at the preclinical stage in Glaucoma & Severe Dry Eye and only one will be retained in the human clinical phase 1.
To learn more about this proposal, email email@example.com.